Finasteride vs Ipilimumab

Finasteride vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Finasteride and Ipilimumab.

Mechanism of Action

Finasteride: Competitive inhibitor of 5-alpha-reductase type II.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Finasteride — 5-6 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Finasteride — C23H36N2O2.

Molecular Weight: Finasteride — 372.5490 g/mol.

Type: Finasteride — Small molecule; Ipilimumab — Antibody.